Evidence map›Paper›PMID 36053368›Full record

ArticleArchives of microbiology2022

Rapid-killing efficacy substantiates the antiseptic property of the synergistic combination of carvacrol and nerol against nosocomial pathogens.

Thirupathi Kasthuri, Thirukannamangai Krishnan Swetha, James Prabhanand Bhaskar, Shunmugiah Karutha Pandian

Open access · bronzeAbstract read
In one paragraph

Article in Archives of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Carvacrol Effectively InhibitsFoods (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Natural compounds in the fight againstFrontiers in pharmacology · 2024
    Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Thirupathi KasthuriDepartment of Biotechnology, Science Campus, Alagappa University, Karaikudi, 630 003, Tamil Nadu, India.
Thirukannamangai Krishnan SwethaDepartment of Biotechnology, Science Campus, Alagappa University, Karaikudi, 630 003, Tamil Nadu, India.
James Prabhanand BhaskarITC Life Sciences and Technology Centre (LSTC), Bengaluru, India.
Shunmugiah Karutha PandianDepartment of Biotechnology, Science Campus, Alagappa University, Karaikudi, 630 003, Tamil Nadu, India. sk_pandian@rediffmail.com.
Alagappa University · INITC (India) · IN

Funding

Department of Science and Technology, INDIA DST/INSPIRE Fellowship/[IF170511]
6 · The paper itself

Abstract

Globally, new classes of synthetic and natural antibiotics and antivirulents have continuously been validated for their potential broad-spectrum antagonistic activity with the aim of identifying an effective active molecule to prevent the spread of infectious agents in both food industry and medical field. In view of this, present study is aimed at evaluating the rapid killing efficacy of bioactive molecules Carvacrol (C) and Nerol (N) through British Standard European Norm 1276: phase2/step1 (EN1276) protocol. Active molecules C and N showed broad-spectrum antimicrobial activity against the test strains Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Enterococcus hirae at concentration range of 78.125, 625, 156.25 and 312.5 μg/mL, respectively, for C, and 625 μg/mL for N. Whereas, combinatorial approach showed efficient activity with four times reduced concentration of C and N at 78.125 and 156.25 µg/mL, respectively, against test strains. Further, EN1276 results proved the rapid killing efficacy of test strains in 1 min of contact time with significant (> 5 log) growth reduction at 100X concentration of actives. SEM analysis and reduced concentration of protease, lipids and carbohydrate contents of treated group biofilm components ascertained preformed biofilm disruption potential of C + N on polystyrene and nail surfaces. C + N at synergistic concentration exhibited no adverse effect on HaCaT cells at 78.125 µg/mL (C) + 156.25 µg/mL (N). Taken together, based on the observed experimental results, present study evidence the antiseptic/disinfectant ability of C + N and suggest that the combination can preferentially be used in foam-based hand wash formulations.

Indexed as

Anti-Infective Agents, LocalCross InfectionAcyclic MonoterpenesAnti-Bacterial AgentsCymenesEscherichia coliHumansMicrobial Sensitivity TestsPseudomonas aeruginosaStaphylococcus aureusAcyclic MonoterpenesAnti-Bacterial AgentsAnti-Infective Agents, LocalcarvacrolCymenesgeraniolAntiseptics/disinfectantsBS: EN1276 protocolHand hygieneNosocomial infectionsPhytocompoundsSynergistic combinations

Identifiers

PMID36053368
PMCPMC9438373
OpenAlexW4294238218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.